1. It’s A Big Weekend For Biotech: http://tradingcommonsense.com/?p=2139 $BIIB $PTCT $ISIS $ALNY $MRK $BMY $NVS $JUNO $BLCM $KITE $ZIOP $INCY $INFI $PCYC

  2. Infinity Pharmaceuticals s General Counsel was just granted 200,000 options http://www.conferencecalltranscripts.org/4/summary2/?id=1615853 $INFI

  3. $INFI: New Insider Transaction on INFI by General Counsel Lam Winston K.C.: http://insideri.com/1639469_000120919115034405_0001209191-15-034405

  4. Infinity Pharmaceuticals s General Counsel just declared ownership of no shares of Infinity Pharmaceuticals http://www.conferencecalltranscripts.org/5/summary2/?id=1615825 $INFI

  5. $INFI: Infinity Augments Executive Leadership Team, Appointing Chief ...... http://stockwires.com/infinity-augments-executive-leadership-team-appointing-chief

  6. $INFI Infinity Augments Executive Leadership Team, Appointing Chief Commercial Officer and General Counsel http://www.finances.com/company-news/84204-infinity-augments-executive-leadership-team-appointing-chief-commercial-officer-and-general-counsel.htm

  7. Pandora, http://www.sohu.com/, Infinity Pharmaceuticals Lead Friday s After-Hours Movers http://www.benzinga.com/news/15/04/5399381/pandora-sohu-com-infinity-pharmaceuticals-lead-fridays-after-hours-movers $P $XOMA $CNAT $SOHU,$INFI

  8. $INFI was one of my 11 stocks to buy at open. It is the only one I did not buy at open & it is the one that performed the most with 7.35%!

  9. @Think4self $ENTA finally has my attention! Looking for a pullback tomorrow but clearly huge bullish flag $INO $INFI $ATHX

  10. $AMRN vs. $ENTA vs. $INFI vs. $HPTX Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=AMRN|ENTA|INFI|HPTX|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  11. After-Hours Losers as of 5:15 p.m.: $EPE -5.6% $MTDR -4.5% $PNR -4.1% $INFI -4.1% $MRGE -4.0%

  12. Healthcare Stocks Big Movers In Tuesday s After Hours Trading http://www.benzinga.com/news/15/04/5389039/regulus-therapeutics-healthcare-stocks-are-big-movers-in-tuesdays-after-hours-tra $FPRX $FTR $INFI $INSY $MNK,$OVAS,$RGLS

  13. $MNTA vs. $INFI vs. $ENTA vs. $HPTX Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=MNTA|INFI|ENTA|HPTX|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  14. $AMRN vs. $INFI vs. $HPTX vs. $SPPI Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=AMRN|INFI|HPTX|SPPI|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  15. Buy candles: $TRAK (36 support) $SSYS (52.70 stp) $KORS (64.40 initial res) $KERX (11.50 stp) $INFI (13 stp) $CRS (37.95 stp)

  16. $EXEL vs. $AEGR vs. $ENTA vs. $INFI Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=EXEL|AEGR|ENTA|INFI|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  17. End Of Day Scan: Below Bollinger Band $LUV $OCUL $CERU $EVR $DWRE $INFI $FUEL $FLWS $FNGN $ARCB

  18. $MNTA vs. $ENTA vs. $AEGR vs. $INFI Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=MNTA|ENTA|AEGR|INFI|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  19. $FOLD vs. $ENTA vs. $INFI vs. $HPTX Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=FOLD|ENTA|INFI|HPTX|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  20. $MNTA vs. $HPTX vs. $AEGR vs. $INFI Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=MNTA|HPTX|AEGR|INFI|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  21. $MNTA vs. $ENTA vs. $INFI Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=MNTA|ENTA|INFI|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  22. End Of Day Scan: Chaikin Money Flow Declining $ORCL $NRG $CRIS $VMW $GALE $PPHM $ATNM $CAPN $INFI $ECL

  23. $EXEL vs. $AEGR vs. $INFI vs. $HPTX Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=EXEL|AEGR|INFI|HPTX|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  24. $INFI - http://www.trade-ideas.com/ticky/ticky.html?symbol=INFI - Yep ... This Up Move is one you are going to like! - New High: +0.11. Next resistance 14.14 from 4/2/2015.

  25. $AMRN vs. $ENTA vs. $SPPI vs. $INFI Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=AMRN|ENTA|SPPI|INFI|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)